Literature DB >> 19279448

Pharmacokinetics of darunavir, etravirine and raltegravir in an HIV-infected patient on haemodialysis.

Pierre Giguère, Charles la Porte, Guijun Zhang, Bill Cameron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19279448     DOI： 10.1097/QAD.0b013e328328f79d

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Minimal removal of raltegravir by hemodialysis in HIV-infected patients with end-stage renal disease.

Authors:  José Moltó; José Sanz-Moreno; Marta Valle; Samandhy Cedeño; Jordi Bonal; Hanane Bouarich; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

Review 2.  Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations.

Authors:  Dario Cattaneo; Cristina Gervasoni
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

3.  Profile of etravirine for the treatment of HIV infection.

Authors:  Alice Tseng; Rodger D Macarthur
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

Review 4.  Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.

Authors:  Anthony T Podany; Kimberly K Scarsi; Courtney V Fletcher
Journal:  Clin Pharmacokinet       Date:  2017-01       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.